Published coverage of the company filing says Nasdaq found the stock closed below USD 1.00 for 30 consecutiveBusinessdays from September 15, 2026 through October 26, 2026. Because reverse splits within two years totalled 1-for-2,000 (1-for-10 on July 8, 2025, 1-for-20 on May 8, 2026 …
Key HighlightsEnact Holdings (NASDAQ:ACT) reported third-quarterNet Incomeof USD 159 million, or USD 1.15 per diluted share, while adjustedOperating Incomewas USD 164 million, or USD 1.19 per share.The company raised its 2026Capitalreturn expectation to approximately USD 600 million and declared a quarterlyDividendof USD 0.24 a …
Chairman and Chief Executive Byron Allen called it a transitional quarter. Following the Allen Family Digital majority stake completed in May 2026, a July restructuring cut about 35% of workforce and dedicated contractors, targeting USD 30 million of annualized savings. Management is focusing on …
Cost of product revenue fell to USD 41.2 million from USD 58.6 million, mainly because normal source plasma sales, a lower-margin line, stopped and BIVIGAMVolumedeclined. Management also credits theYieldenhancement process approved by the FDA in April 2025, which it says raises ASCENIV and BIVIGAM …
A reverse split cuts the share count and lifts the quoted price in proportion, but it does not change the company's total market value. Its usual purpose is to satisfy theNasdaqminimum bid rule, and published coverage indicates compliance was regained on September 17, 2026. …
Key HighlightsAdient (NYSE:ADNT) reported a fiscal fourth-quarterGAAPnet loss attributable to the company of USD 47 million, or USD 0.62 per share, against income of USD 18 million, or USD 0.22, a year earlier.AdjustedDiluted Earnings per Sharewere unchanged at USD 0.52, as adjustedNet Incomeslipped to …
Vafseo is the growth story: about 11,500 patients were on therapy at quarter end, up about 8.1% from the second quarter and about 140% from a year earlier, with about 1,300 prescribers. Management said third-quarter Vafseo revenue was below the second quarter mainly because …
Operating results moved from a USD 10.3 million profit to a USD 0.5 million loss. Cost of revenue rose to USD 19.9 million, sales andMarketingexpenses climbed 15% to USD 26.9 million, andResearch and Developmentfell 21% to USD 18.6 million after restructuring. MRD adjusted EBITDA, …
Ironton produced 5.2 million pounds of PureFive resin, up from 4.5 million pounds in the second quarter but below 7.3 million pounds a year earlier. Management said operational issues were resolved and output now matches current demand. About 15 food-contact programs, roughly 50 million …
Key HighlightsAeva Technologies (NASDAQ:AEVA) reported record third-quarterRevenueof USD 6.7 million, up from USD 3.6 million, an 86.3% increase (calculated), with product revenue of USD 3.5 million and professional services of USD 3.2 million.GAAP operating loss widened to USD 39.1 million from USD 33.2 million, …